Biotechnology Ultrasector Profund Fund Manager Performance Evaluation
| BIPIX Fund | USD 71.95 0.14 0.19% |
The fund shows a Beta (market volatility) of 1.08, which signifies a somewhat significant risk relative to the market. Biotechnology Ultrasector returns are very sensitive to returns on the market. As the market goes up or down, Biotechnology Ultrasector is expected to follow.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Biotechnology Ultrasector showed solid returns over the last few months and may actually be approaching a breakup point.
...more| Expense Ratio Date | 28th of November 2025 | |
| Expense Ratio | 1.5200 |
Biotechnology |
Biotechnology Ultrasector Relative Risk vs. Return Landscape
If you would invest 5,954 in Biotechnology Ultrasector Profund on October 28, 2025 and sell it today you would earn a total of 1,241 from holding Biotechnology Ultrasector Profund or generate 20.84% return on investment over 90 days. Biotechnology Ultrasector Profund is currently producing 0.3384% returns and takes up 2.3718% volatility of returns over 90 trading days. Put another way, 21% of traded mutual funds are less volatile than Biotechnology, and 94% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Biotechnology Ultrasector Current Valuation
Undervalued
Today
Please note that Biotechnology Ultrasector's price fluctuation is very steady at this time. At this time, the entity appears to be undervalued. Biotechnology Ultrasector shows a prevailing Real Value of $74.86 per share. The current price of the fund is $71.95. We determine the value of Biotechnology Ultrasector from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Biotechnology Ultrasector is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotechnology Mutual Fund. However, Biotechnology Ultrasector's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 71.95 | Real 74.86 | Hype 71.95 | Naive 73.49 |
The intrinsic value of Biotechnology Ultrasector's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotechnology Ultrasector's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotechnology Ultrasector Profund helps investors to forecast how Biotechnology mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotechnology Ultrasector more accurately as focusing exclusively on Biotechnology Ultrasector's fundamentals will not take into account other important factors: Biotechnology Ultrasector Target Price Odds to finish over Current Price
The tendency of Biotechnology Mutual Fund price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 71.95 | 90 days | 71.95 | about 8.76 |
Based on a normal probability distribution, the odds of Biotechnology Ultrasector to move above the current price in 90 days from now is about 8.76 (This Biotechnology Ultrasector Profund probability density function shows the probability of Biotechnology Mutual Fund to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the mutual fund has the beta coefficient of 1.08 suggesting Biotechnology Ultrasector Profund market returns are sensitive to returns on the market. As the market goes up or down, Biotechnology Ultrasector is expected to follow. Additionally Biotechnology Ultrasector Profund has an alpha of 0.279, implying that it can generate a 0.28 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Biotechnology Ultrasector Price Density |
| Price |
Predictive Modules for Biotechnology Ultrasector
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotechnology Ultrasector. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biotechnology Ultrasector Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biotechnology Ultrasector is not an exception. The market had few large corrections towards the Biotechnology Ultrasector's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biotechnology Ultrasector Profund, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biotechnology Ultrasector within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.28 | |
β | Beta against Dow Jones | 1.08 | |
σ | Overall volatility | 5.06 | |
Ir | Information ratio | 0.12 |
Biotechnology Ultrasector Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotechnology Ultrasector for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotechnology Ultrasector can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The fund holds about 24.54% of its assets under management (AUM) in cash |
Biotechnology Ultrasector Fundamentals Growth
Biotechnology Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Biotechnology Ultrasector, and Biotechnology Ultrasector fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotechnology Mutual Fund performance.
| Price To Earning | 2.37 X | |||
| Price To Book | 5.19 X | |||
| Price To Sales | 4.56 X | |||
| Total Asset | 175.48 M | |||
About Biotechnology Ultrasector Performance
Evaluating Biotechnology Ultrasector's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Biotechnology Ultrasector has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biotechnology Ultrasector has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The index is designed to measure the performance of biotechnology companies included in the SP Total Market Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80 percent of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.Things to note about Biotechnology Ultrasector performance evaluation
Checking the ongoing alerts about Biotechnology Ultrasector for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Biotechnology Ultrasector help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The fund holds about 24.54% of its assets under management (AUM) in cash |
- Analyzing Biotechnology Ultrasector's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotechnology Ultrasector's stock is overvalued or undervalued compared to its peers.
- Examining Biotechnology Ultrasector's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotechnology Ultrasector's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotechnology Ultrasector's management team can help you assess the Mutual Fund's leadership.
- Pay attention to analyst opinions and ratings of Biotechnology Ultrasector's mutual fund. These opinions can provide insight into Biotechnology Ultrasector's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |